Industry Research Reports
Global Levodopa Market Research Report 2025
Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 101 Pages
Report ld: 4156282
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Levodopa was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Levodopa is one of the main drugs used to treat Parkinson"s symptoms. It can be used at all stages of the condition. The statistic scope is Levodopa API in this report.
North American market for Levodopa is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Levodopa is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Levodopa include Shandong Xinhua Pharmaceutical Co, Ajinomoto, Daiichi Sankyo Chemical Pharma Co, Delmar Chemicals Inc, Divis Laboratories Ltd, Egis Pharmaceuticals Private Ltd, Hangzhou Longshine Bio-Tech Co, Hoffmann La Roche Inc, Suzhou Ryway Biotech, Teva Pharmaceutical Industries Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
By Company
- Shandong Xinhua Pharmaceutical Co
- Ajinomoto
- Daiichi Sankyo Chemical Pharma Co
- Delmar Chemicals Inc
- Divis Laboratories Ltd
- Egis Pharmaceuticals Private Ltd
- Hangzhou Longshine Bio-Tech Co
- Hoffmann La Roche Inc
- Suzhou Ryway Biotech
- Teva Pharmaceutical Industries Ltd
- Torrent Pharmaceuticals Limited
- Zhejiang Huahai Pharmaceutical Co
- Zhejiang Wild Wind Pharmaceutical
- Broahony Group
- Lanpharma Chemical Co
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity: 98%
- Purity: 99%
Segment by Application
- Tablet Products
- Capsule Products
- Others
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Levodopa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Levodopa.
The Levodopa market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Levodopa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Levodopa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Levodopa manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Levodopa by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Levodopa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Levodopa Market Overview
1.1 Product Definition
1.2 Levodopa by Type
1.2.1 Global Levodopa Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity: 98%
1.2.3 Purity: 99%
1.3 Levodopa by Application
1.3.1 Global Levodopa Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablet Products
1.3.3 Capsule Products
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Levodopa Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Levodopa Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Levodopa Production Estimates and Forecasts (2020-2031)
1.4.4 Global Levodopa Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Levodopa Production Market Share by Manufacturers (2020-2025)
2.2 Global Levodopa Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Levodopa, Industry Ranking, 2023 VS 2024
2.4 Global Levodopa Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Levodopa Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Levodopa, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Levodopa, Product Offered and Application
2.8 Global Key Manufacturers of Levodopa, Date of Enter into This Industry
2.9 Levodopa Market Competitive Situation and Trends
2.9.1 Levodopa Market Concentration Rate
2.9.2 Global 5 and 10 Largest Levodopa Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Levodopa Production by Region
3.1 Global Levodopa Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Levodopa Production Value by Region (2020-2031)
3.2.1 Global Levodopa Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Levodopa by Region (2026-2031)
3.3 Global Levodopa Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Levodopa Production Volume by Region (2020-2031)
3.4.1 Global Levodopa Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Levodopa by Region (2026-2031)
3.5 Global Levodopa Market Price Analysis by Region (2020-2025)
3.6 Global Levodopa Production and Value, Year-over-Year Growth
3.6.1 North America Levodopa Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Levodopa Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Levodopa Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Levodopa Production Value Estimates and Forecasts (2020-2031)
4 Levodopa Consumption by Region
4.1 Global Levodopa Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Levodopa Consumption by Region (2020-2031)
4.2.1 Global Levodopa Consumption by Region (2020-2025)
4.2.2 Global Levodopa Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Levodopa Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Levodopa Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Levodopa Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Levodopa Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Levodopa Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Levodopa Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Levodopa Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Levodopa Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Levodopa Production by Type (2020-2031)
5.1.1 Global Levodopa Production by Type (2020-2025)
5.1.2 Global Levodopa Production by Type (2026-2031)
5.1.3 Global Levodopa Production Market Share by Type (2020-2031)
5.2 Global Levodopa Production Value by Type (2020-2031)
5.2.1 Global Levodopa Production Value by Type (2020-2025)
5.2.2 Global Levodopa Production Value by Type (2026-2031)
5.2.3 Global Levodopa Production Value Market Share by Type (2020-2031)
5.3 Global Levodopa Price by Type (2020-2031)
6 Segment by Application
6.1 Global Levodopa Production by Application (2020-2031)
6.1.1 Global Levodopa Production by Application (2020-2025)
6.1.2 Global Levodopa Production by Application (2026-2031)
6.1.3 Global Levodopa Production Market Share by Application (2020-2031)
6.2 Global Levodopa Production Value by Application (2020-2031)
6.2.1 Global Levodopa Production Value by Application (2020-2025)
6.2.2 Global Levodopa Production Value by Application (2026-2031)
6.2.3 Global Levodopa Production Value Market Share by Application (2020-2031)
6.3 Global Levodopa Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Shandong Xinhua Pharmaceutical Co
7.1.1 Shandong Xinhua Pharmaceutical Co Levodopa Company Information
7.1.2 Shandong Xinhua Pharmaceutical Co Levodopa Product Portfolio
7.1.3 Shandong Xinhua Pharmaceutical Co Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Shandong Xinhua Pharmaceutical Co Main Business and Markets Served
7.1.5 Shandong Xinhua Pharmaceutical Co Recent Developments/Updates
7.2 Ajinomoto
7.2.1 Ajinomoto Levodopa Company Information
7.2.2 Ajinomoto Levodopa Product Portfolio
7.2.3 Ajinomoto Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Ajinomoto Main Business and Markets Served
7.2.5 Ajinomoto Recent Developments/Updates
7.3 Daiichi Sankyo Chemical Pharma Co
7.3.1 Daiichi Sankyo Chemical Pharma Co Levodopa Company Information
7.3.2 Daiichi Sankyo Chemical Pharma Co Levodopa Product Portfolio
7.3.3 Daiichi Sankyo Chemical Pharma Co Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Daiichi Sankyo Chemical Pharma Co Main Business and Markets Served
7.3.5 Daiichi Sankyo Chemical Pharma Co Recent Developments/Updates
7.4 Delmar Chemicals Inc
7.4.1 Delmar Chemicals Inc Levodopa Company Information
7.4.2 Delmar Chemicals Inc Levodopa Product Portfolio
7.4.3 Delmar Chemicals Inc Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Delmar Chemicals Inc Main Business and Markets Served
7.4.5 Delmar Chemicals Inc Recent Developments/Updates
7.5 Divis Laboratories Ltd
7.5.1 Divis Laboratories Ltd Levodopa Company Information
7.5.2 Divis Laboratories Ltd Levodopa Product Portfolio
7.5.3 Divis Laboratories Ltd Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Divis Laboratories Ltd Main Business and Markets Served
7.5.5 Divis Laboratories Ltd Recent Developments/Updates
7.6 Egis Pharmaceuticals Private Ltd
7.6.1 Egis Pharmaceuticals Private Ltd Levodopa Company Information
7.6.2 Egis Pharmaceuticals Private Ltd Levodopa Product Portfolio
7.6.3 Egis Pharmaceuticals Private Ltd Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Egis Pharmaceuticals Private Ltd Main Business and Markets Served
7.6.5 Egis Pharmaceuticals Private Ltd Recent Developments/Updates
7.7 Hangzhou Longshine Bio-Tech Co
7.7.1 Hangzhou Longshine Bio-Tech Co Levodopa Company Information
7.7.2 Hangzhou Longshine Bio-Tech Co Levodopa Product Portfolio
7.7.3 Hangzhou Longshine Bio-Tech Co Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Hangzhou Longshine Bio-Tech Co Main Business and Markets Served
7.7.5 Hangzhou Longshine Bio-Tech Co Recent Developments/Updates
7.8 Hoffmann La Roche Inc
7.8.1 Hoffmann La Roche Inc Levodopa Company Information
7.8.2 Hoffmann La Roche Inc Levodopa Product Portfolio
7.8.3 Hoffmann La Roche Inc Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Hoffmann La Roche Inc Main Business and Markets Served
7.8.5 Hoffmann La Roche Inc Recent Developments/Updates
7.9 Suzhou Ryway Biotech
7.9.1 Suzhou Ryway Biotech Levodopa Company Information
7.9.2 Suzhou Ryway Biotech Levodopa Product Portfolio
7.9.3 Suzhou Ryway Biotech Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Suzhou Ryway Biotech Main Business and Markets Served
7.9.5 Suzhou Ryway Biotech Recent Developments/Updates
7.10 Teva Pharmaceutical Industries Ltd
7.10.1 Teva Pharmaceutical Industries Ltd Levodopa Company Information
7.10.2 Teva Pharmaceutical Industries Ltd Levodopa Product Portfolio
7.10.3 Teva Pharmaceutical Industries Ltd Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Teva Pharmaceutical Industries Ltd Main Business and Markets Served
7.10.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.11 Torrent Pharmaceuticals Limited
7.11.1 Torrent Pharmaceuticals Limited Levodopa Company Information
7.11.2 Torrent Pharmaceuticals Limited Levodopa Product Portfolio
7.11.3 Torrent Pharmaceuticals Limited Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Torrent Pharmaceuticals Limited Main Business and Markets Served
7.11.5 Torrent Pharmaceuticals Limited Recent Developments/Updates
7.12 Zhejiang Huahai Pharmaceutical Co
7.12.1 Zhejiang Huahai Pharmaceutical Co Levodopa Company Information
7.12.2 Zhejiang Huahai Pharmaceutical Co Levodopa Product Portfolio
7.12.3 Zhejiang Huahai Pharmaceutical Co Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Zhejiang Huahai Pharmaceutical Co Main Business and Markets Served
7.12.5 Zhejiang Huahai Pharmaceutical Co Recent Developments/Updates
7.13 Zhejiang Wild Wind Pharmaceutical
7.13.1 Zhejiang Wild Wind Pharmaceutical Levodopa Company Information
7.13.2 Zhejiang Wild Wind Pharmaceutical Levodopa Product Portfolio
7.13.3 Zhejiang Wild Wind Pharmaceutical Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Zhejiang Wild Wind Pharmaceutical Main Business and Markets Served
7.13.5 Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
7.14 Broahony Group
7.14.1 Broahony Group Levodopa Company Information
7.14.2 Broahony Group Levodopa Product Portfolio
7.14.3 Broahony Group Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Broahony Group Main Business and Markets Served
7.14.5 Broahony Group Recent Developments/Updates
7.15 Lanpharma Chemical Co
7.15.1 Lanpharma Chemical Co Levodopa Company Information
7.15.2 Lanpharma Chemical Co Levodopa Product Portfolio
7.15.3 Lanpharma Chemical Co Levodopa Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Lanpharma Chemical Co Main Business and Markets Served
7.15.5 Lanpharma Chemical Co Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Levodopa Industry Chain Analysis
8.2 Levodopa Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Levodopa Production Mode & Process Analysis
8.4 Levodopa Sales and Marketing
8.4.1 Levodopa Sales Channels
8.4.2 Levodopa Distributors
8.5 Levodopa Customer Analysis
9 Levodopa Market Dynamics
9.1 Levodopa Industry Trends
9.2 Levodopa Market Drivers
9.3 Levodopa Market Challenges
9.4 Levodopa Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Levodopa Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Levodopa Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Levodopa Production Capacity (MT) by Manufacturers in 2024
Table 4. Global Levodopa Production by Manufacturers (2020-2025) & (MT)
Table 5. Global Levodopa Production Market Share by Manufacturers (2020-2025)
Table 6. Global Levodopa Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Levodopa Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Levodopa, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Levodopa as of 2024)
Table 10. Global Market Levodopa Average Price by Manufacturers (USD/MT) & (2020-2025)
Table 11. Global Key Manufacturers of Levodopa, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Levodopa, Product Offered and Application
Table 13. Global Key Manufacturers of Levodopa, Date of Enter into This Industry
Table 14. Global Levodopa Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Levodopa Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Levodopa Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Levodopa Production Value Market Share by Region (2020-2025)
Table 19. Global Levodopa Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Levodopa Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Levodopa Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)
Table 22. Global Levodopa Production (MT) by Region (2020-2025)
Table 23. Global Levodopa Production Market Share by Region (2020-2025)
Table 24. Global Levodopa Production (MT) Forecast by Region (2026-2031)
Table 25. Global Levodopa Production Market Share Forecast by Region (2026-2031)
Table 26. Global Levodopa Market Average Price (USD/MT) by Region (2020-2025)
Table 27. Global Levodopa Market Average Price (USD/MT) by Region (2026-2031)
Table 28. Global Levodopa Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)
Table 29. Global Levodopa Consumption by Region (2020-2025) & (MT)
Table 30. Global Levodopa Consumption Market Share by Region (2020-2025)
Table 31. Global Levodopa Forecasted Consumption by Region (2026-2031) & (MT)
Table 32. Global Levodopa Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Levodopa Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
Table 34. North America Levodopa Consumption by Country (2020-2025) & (MT)
Table 35. North America Levodopa Consumption by Country (2026-2031) & (MT)
Table 36. Europe Levodopa Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
Table 37. Europe Levodopa Consumption by Country (2020-2025) & (MT)
Table 38. Europe Levodopa Consumption by Country (2026-2031) & (MT)
Table 39. Asia Pacific Levodopa Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (MT)
Table 40. Asia Pacific Levodopa Consumption by Region (2020-2025) & (MT)
Table 41. Asia Pacific Levodopa Consumption by Region (2026-2031) & (MT)
Table 42. Latin America, Middle East & Africa Levodopa Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (MT)
Table 43. Latin America, Middle East & Africa Levodopa Consumption by Country (2020-2025) & (MT)
Table 44. Latin America, Middle East & Africa Levodopa Consumption by Country (2026-2031) & (MT)
Table 45. Global Levodopa Production (MT) by Type (2020-2025)
Table 46. Global Levodopa Production (MT) by Type (2026-2031)
Table 47. Global Levodopa Production Market Share by Type (2020-2025)
Table 48. Global Levodopa Production Market Share by Type (2026-2031)
Table 49. Global Levodopa Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Levodopa Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Levodopa Production Value Market Share by Type (2020-2025)
Table 52. Global Levodopa Production Value Market Share by Type (2026-2031)
Table 53. Global Levodopa Price (USD/MT) by Type (2020-2025)
Table 54. Global Levodopa Price (USD/MT) by Type (2026-2031)
Table 55. Global Levodopa Production (MT) by Application (2020-2025)
Table 56. Global Levodopa Production (MT) by Application (2026-2031)
Table 57. Global Levodopa Production Market Share by Application (2020-2025)
Table 58. Global Levodopa Production Market Share by Application (2026-2031)
Table 59. Global Levodopa Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Levodopa Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Levodopa Production Value Market Share by Application (2020-2025)
Table 62. Global Levodopa Production Value Market Share by Application (2026-2031)
Table 63. Global Levodopa Price (USD/MT) by Application (2020-2025)
Table 64. Global Levodopa Price (USD/MT) by Application (2026-2031)
Table 65. Shandong Xinhua Pharmaceutical Co Levodopa Company Information
Table 66. Shandong Xinhua Pharmaceutical Co Levodopa Specification and Application
Table 67. Shandong Xinhua Pharmaceutical Co Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 68. Shandong Xinhua Pharmaceutical Co Main Business and Markets Served
Table 69. Shandong Xinhua Pharmaceutical Co Recent Developments/Updates
Table 70. Ajinomoto Levodopa Company Information
Table 71. Ajinomoto Levodopa Specification and Application
Table 72. Ajinomoto Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. Ajinomoto Main Business and Markets Served
Table 74. Ajinomoto Recent Developments/Updates
Table 75. Daiichi Sankyo Chemical Pharma Co Levodopa Company Information
Table 76. Daiichi Sankyo Chemical Pharma Co Levodopa Specification and Application
Table 77. Daiichi Sankyo Chemical Pharma Co Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Daiichi Sankyo Chemical Pharma Co Main Business and Markets Served
Table 79. Daiichi Sankyo Chemical Pharma Co Recent Developments/Updates
Table 80. Delmar Chemicals Inc Levodopa Company Information
Table 81. Delmar Chemicals Inc Levodopa Specification and Application
Table 82. Delmar Chemicals Inc Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Delmar Chemicals Inc Main Business and Markets Served
Table 84. Delmar Chemicals Inc Recent Developments/Updates
Table 85. Divis Laboratories Ltd Levodopa Company Information
Table 86. Divis Laboratories Ltd Levodopa Specification and Application
Table 87. Divis Laboratories Ltd Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Divis Laboratories Ltd Main Business and Markets Served
Table 89. Divis Laboratories Ltd Recent Developments/Updates
Table 90. Egis Pharmaceuticals Private Ltd Levodopa Company Information
Table 91. Egis Pharmaceuticals Private Ltd Levodopa Specification and Application
Table 92. Egis Pharmaceuticals Private Ltd Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Egis Pharmaceuticals Private Ltd Main Business and Markets Served
Table 94. Egis Pharmaceuticals Private Ltd Recent Developments/Updates
Table 95. Hangzhou Longshine Bio-Tech Co Levodopa Company Information
Table 96. Hangzhou Longshine Bio-Tech Co Levodopa Specification and Application
Table 97. Hangzhou Longshine Bio-Tech Co Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Hangzhou Longshine Bio-Tech Co Main Business and Markets Served
Table 99. Hangzhou Longshine Bio-Tech Co Recent Developments/Updates
Table 100. Hoffmann La Roche Inc Levodopa Company Information
Table 101. Hoffmann La Roche Inc Levodopa Specification and Application
Table 102. Hoffmann La Roche Inc Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Hoffmann La Roche Inc Main Business and Markets Served
Table 104. Hoffmann La Roche Inc Recent Developments/Updates
Table 105. Suzhou Ryway Biotech Levodopa Company Information
Table 106. Suzhou Ryway Biotech Levodopa Specification and Application
Table 107. Suzhou Ryway Biotech Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Suzhou Ryway Biotech Main Business and Markets Served
Table 109. Suzhou Ryway Biotech Recent Developments/Updates
Table 110. Teva Pharmaceutical Industries Ltd Levodopa Company Information
Table 111. Teva Pharmaceutical Industries Ltd Levodopa Specification and Application
Table 112. Teva Pharmaceutical Industries Ltd Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Teva Pharmaceutical Industries Ltd Main Business and Markets Served
Table 114. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 115. Torrent Pharmaceuticals Limited Levodopa Company Information
Table 116. Torrent Pharmaceuticals Limited Levodopa Specification and Application
Table 117. Torrent Pharmaceuticals Limited Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Torrent Pharmaceuticals Limited Main Business and Markets Served
Table 119. Torrent Pharmaceuticals Limited Recent Developments/Updates
Table 120. Zhejiang Huahai Pharmaceutical Co Levodopa Company Information
Table 121. Zhejiang Huahai Pharmaceutical Co Levodopa Specification and Application
Table 122. Zhejiang Huahai Pharmaceutical Co Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Zhejiang Huahai Pharmaceutical Co Main Business and Markets Served
Table 124. Zhejiang Huahai Pharmaceutical Co Recent Developments/Updates
Table 125. Zhejiang Wild Wind Pharmaceutical Levodopa Company Information
Table 126. Zhejiang Wild Wind Pharmaceutical Levodopa Specification and Application
Table 127. Zhejiang Wild Wind Pharmaceutical Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 128. Zhejiang Wild Wind Pharmaceutical Main Business and Markets Served
Table 129. Zhejiang Wild Wind Pharmaceutical Recent Developments/Updates
Table 130. Broahony Group Levodopa Company Information
Table 131. Broahony Group Levodopa Specification and Application
Table 132. Broahony Group Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 133. Broahony Group Main Business and Markets Served
Table 134. Broahony Group Recent Developments/Updates
Table 135. Lanpharma Chemical Co Levodopa Company Information
Table 136. Lanpharma Chemical Co Levodopa Specification and Application
Table 137. Lanpharma Chemical Co Levodopa Production (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 138. Lanpharma Chemical Co Main Business and Markets Served
Table 139. Lanpharma Chemical Co Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Levodopa Distributors List
Table 143. Levodopa Customers List
Table 144. Levodopa Market Trends
Table 145. Levodopa Market Drivers
Table 146. Levodopa Market Challenges
Table 147. Levodopa Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Levodopa
Figure 2. Global Levodopa Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Levodopa Market Share by Type: 2024 VS 2031
Figure 4. Purity: 98% Product Picture
Figure 5. Purity: 99% Product Picture
Figure 6. Global Levodopa Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Levodopa Market Share by Application: 2024 VS 2031
Figure 8. Tablet Products
Figure 9. Capsule Products
Figure 10. Others
Figure 11. Global Levodopa Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Levodopa Production Value (US$ Million) & (2020-2031)
Figure 13. Global Levodopa Production Capacity (MT) & (2020-2031)
Figure 14. Global Levodopa Production (MT) & (2020-2031)
Figure 15. Global Levodopa Average Price (USD/MT) & (2020-2031)
Figure 16. Levodopa Report Years Considered
Figure 17. Levodopa Production Share by Manufacturers in 2024
Figure 18. Global Levodopa Production Value Share by Manufacturers (2024)
Figure 19. Levodopa Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. The Global 5 and 10 Largest Players: Market Share by Levodopa Revenue in 2024
Figure 21. Global Levodopa Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 22. Global Levodopa Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 23. Global Levodopa Production Comparison by Region: 2020 VS 2024 VS 2031 (MT)
Figure 24. Global Levodopa Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. North America Levodopa Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. Europe Levodopa Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. China Levodopa Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Levodopa Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. Global Levodopa Consumption by Region: 2020 VS 2024 VS 2031 (MT)
Figure 30. Global Levodopa Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 31. North America Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 32. North America Levodopa Consumption Market Share by Country (2020-2031)
Figure 33. U.S. Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 34. Canada Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 35. Europe Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 36. Europe Levodopa Consumption Market Share by Country (2020-2031)
Figure 37. Germany Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 38. France Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 39. U.K. Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 40. Italy Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 41. Russia Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 42. Asia Pacific Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 43. Asia Pacific Levodopa Consumption Market Share by Region (2020-2031)
Figure 44. China Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 45. Japan Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 46. South Korea Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 47. China Taiwan Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 48. Southeast Asia Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 49. India Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 50. Latin America, Middle East & Africa Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 51. Latin America, Middle East & Africa Levodopa Consumption Market Share by Country (2020-2031)
Figure 52. Mexico Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 53. Brazil Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 54. Turkey Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 55. GCC Countries Levodopa Consumption and Growth Rate (2020-2031) & (MT)
Figure 56. Global Production Market Share of Levodopa by Type (2020-2031)
Figure 57. Global Production Value Market Share of Levodopa by Type (2020-2031)
Figure 58. Global Levodopa Price (USD/MT) by Type (2020-2031)
Figure 59. Global Production Market Share of Levodopa by Application (2020-2031)
Figure 60. Global Production Value Market Share of Levodopa by Application (2020-2031)
Figure 61. Global Levodopa Price (USD/MT) by Application (2020-2031)
Figure 62. Levodopa Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Levodopa market?
The top companies in the global Levodopa market are Shandong Xinhua Pharmaceutical Co、Ajinomoto、Daiichi Sankyo Chemical Pharma Co.
Related Reports
Levodopa- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Levodopa was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 144
USD 3950.00
(Single User License)
Global Levodopa Market Research Report 2026
The global Levodopa market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 138
USD 2900.00
(Single User License)
Global Levodopa Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Levodopa market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 152
USD 4900.00
(Single User License)
Global Levodopa Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Levodopa market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 98
USD 4250.00
(Single User License)
Levodopa- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Levodopa was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 122
USD 3950.00
(Single User License)
Global Levodopa Market Insights, Forecast to 2030
Levodopa is a naturally occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs, and is synthesized from the amino acid L-tyrosine in the mammalian body and brain.
Published Date: 2024-04-07
Pages: 93
USD 4900.00
(Single User License)
Levodopa - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Levodopa is one of the main drugs used to treat Parkinson's symptoms. It can be used at all stages of the condition. The statistic scope is Levodopa API in this report.
Published Date: 2024-01-25
Pages: 136
USD 3950.00
(Single User License)
Global Levodopa Market Research Report 2024
Levodopa is a naturally occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs, and is synthesized from the amino acid L-tyrosine in the mammalian body and brain.
Published Date: 2024-01-10
Pages: 91
USD 2900.00
(Single User License)
Levodopa- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Levodopa was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 144
USD 3950.00 (Single User License)Global Levodopa Market Research Report 2026
The global Levodopa market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 138
USD 2900.00 (Single User License)Global Levodopa Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Levodopa market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 152
USD 4900.00 (Single User License)Global Levodopa Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Levodopa market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 98
USD 4250.00 (Single User License)Levodopa- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Levodopa was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 122
USD 3950.00 (Single User License)Global Levodopa Market Insights, Forecast to 2030
Levodopa is a naturally occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs, and is synthesized from the amino acid L-tyrosine in the mammalian body and brain.
Published: 2024-04-07
Pages: 93
USD 4900.00 (Single User License)Levodopa - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Levodopa is one of the main drugs used to treat Parkinson's symptoms. It can be used at all stages of the condition. The statistic scope is Levodopa API in this report.
Published: 2024-01-25
Pages: 136
USD 3950.00 (Single User License)Global Levodopa Market Research Report 2024
Levodopa is a naturally occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs, and is synthesized from the amino acid L-tyrosine in the mammalian body and brain.
Published: 2024-01-10
Pages: 91
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now